Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $152383.0.

  • 60 Degrees Pharmaceuticals' Other Non-Current Assets fell 5932.6% to $152383.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $152383.0, marking a year-over-year decrease of 5932.6%. This contributed to the annual value of $223260.0 for FY2024, which is 5381.67% down from last year.
  • According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Other Non-Current Assets is $152383.0, which was down 5932.6% from $143704.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Other Non-Current Assets ranged from a high of $1.7 million in Q2 2023 and a low of $143704.0 during Q2 2025
  • Its 4-year average for Other Non-Current Assets is $406794.6, with a median of $251581.0 in 2023.
  • Per our database at Business Quant, 60 Degrees Pharmaceuticals' Other Non-Current Assets surged by 17327.11% in 2023 and then crashed by 7587.2% in 2024.
  • Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Other Non-Current Assets stood at $176902.0 in 2022, then surged by 173.27% to $483422.0 in 2023, then tumbled by 53.82% to $223260.0 in 2024, then crashed by 31.75% to $152383.0 in 2025.
  • Its Other Non-Current Assets stands at $152383.0 for Q3 2025, versus $143704.0 for Q2 2025 and $171844.0 for Q1 2025.